Intraoperative Floppy Iris Syndrome Clinical Trial
Official title:
Enhanced Pupil Dilation in Patients Taking Alpha-Blockers for Potential Treatment of Intraoperative Floppy Iris Syndrome
A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.
This study explores the effects that medication can have on increasing pupil dilation. Pupil dilation size is important for operative eye procedures. Decreased pupil size is related to increased complication risks in eye surgery. By exploring novel pupil dilation techniques, there is a potential to counteract the effects of poor pupil dilation that is caused by medications such as alpha-blockers. Intraoperative floppy iris syndrome is a syndrome characterized by a floppy iris (IFIS) and poor pupil dilation during surgery that is caused by BPH medications. This study evaluates treatment methods targeting IFIS. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01693575 -
Use of APX 100 Device for Small-pupil Cataract Surgery and Intraoperative Floppy-iris Syndrome
|
N/A | |
| Recruiting |
NCT01070602 -
The Effect of Anterior Corneal Incisions on Intraoperative Floppy Iris Syndrome (IFIS) Incidence and Severity in Tamsulosin Treated Cataract Patients
|
N/A | |
| Completed |
NCT06266962 -
Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome
|
Phase 4 | |
| Completed |
NCT01704014 -
Intraoperative Floppy Iris Syndrome in Korean Patients Taking α1-Adrenergic Receptor Antagonists
|
N/A | |
| Terminated |
NCT02093689 -
Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery
|
Phase 3 | |
| Terminated |
NCT00627913 -
Retrobulbar Injection of Anesthesia Versus Healon 5 in the Management of Intraoperative Floppy Iris Syndrome
|
N/A |